Evidence map›Paper›PMID 28079059›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Juan Pablo Lopez, Fabricio Pereira, Stéphane Richard-Devantoy, Marcelo Berlim, Eduardo Chachamovich, Laura M Fiori, Paola Niola, Gustavo Turecki, Fabrice Jollant

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. The miRNome of Depression.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. miRNAs in depression vulnerability and resilience: novel targets for preventive strategies.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Juan Pablo LopezMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Fabricio PereiraDepartment of Radiology, Nîmes Academic Hospital, Nîmes, France &EA 2415, Montpellier University, Montpellier, France.ORCID http://orcid.org/0000-0003-3317-8756
Stéphane Richard-DevantoyMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Marcelo BerlimMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Eduardo ChachamovichMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Laura M FioriMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Paola NiolaLaboratory of Pharmacogenomics, Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Gustavo TureckiMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Fabrice JollantMcGill Group for Suicide Studies, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Douglas Mental Health University Institute · CAUniversité de Montpellier · FRUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are short non-coding molecules that play a major role in regulating gene expression. Peripheral levels of miR-1202 have been shown to predict and mediate antidepressant response. However, it is not clear to what extent these peripheral measures reflect central neural changes in vivo. We approached this problem with the combined use of peripheral miR-1202 measures and neuroimaging. At baseline and after 8 weeks of desvenlafaxine (50-100 mg die), 20 patients were scanned with 3T magnetic resonance imaging, first at rest then during the Go/NoGo task, a classical test of response inhibition. Blood samples were collected at both time points. During resting state, lower baseline miR-1202 levels were predictive of increased connectivity from T0 to T8 between the posterior cingulate and the prefrontal, parietal, and occipital cortices. Changes in miR-1202 levels following desvenlafaxine treatment were negatively correlated with changes in activity in right precuneus within the default-mode network, and in connectivity between the posterior cingulate and the temporal and prefrontal cortices, and the precuneus. During the Go/NoGo task, baseline miR-1202 levels and changes in these levels were correlated with activity changes in different regions, including bilateral prefrontal, insular, cingulate, and temporal cortices, and left putamen and claustrum. Finally, secondary analyses in a subset of patients showed a trend for a significant correlation between miR-1202 levels and glutamate levels measured by spectroscopy. Changes in peripheral miR-1202 levels were therefore associated with changes in brain activity and connectivity in a network of brain regions associated with depression and antidepressant response. These effects may be mediated by the glutamatergic system.

Indexed as

AdultAntidepressive AgentsBrainBrain MappingDesvenlafaxine SuccinateFemaleHumansInhibition, PsychologicalMagnetic Resonance ImagingMajor Depressive DisorderMaleMicroRNAsMotor ActivityNeural PathwaysNeuropsychological TestsRestAntidepressive AgentsDesvenlafaxine SuccinateMicroRNAsMIRN1202 microRNA, humanSerotonin and Noradrenaline Reuptake Inhibitors

Identifiers

PMID28079059
PMCPMC5561353
OpenAlexW2578849970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.